Brock Lesnar’s troubles continue as the USADA has notified the UFC of a failed in competition drug test collected at UFC 200. The in competition test found the same substance that was found in the first failed out of competition sample. The UFC released the following statement:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016,” UFC officials said in a statement.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
The substance that caused the failure of both in and out of competition tests is still to be revealed but the commission may release the information once hearings commence. The USADA can punish Lesnar with a suspension ranging from two years to four years depending on the circumstances relating to the drug test failures.
Keep it locked to RAGE Works and MTR as this story continues to develop.